# Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

> **NCT04204811** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 22 (estimated)

## Conditions studied

- Ovarian Cancer
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Carcinoma
- Fallopian Tube Cancer

## Interventions

- **OTHER:** Prehabilitation

## Key facts

- **NCT ID:** NCT04204811
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-16
- **Primary completion:** 2026-12-16
- **Final completion:** 2026-12-16
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04204811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04204811, "Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04204811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*